Clinicopathologic Conference, Anti-IgLON5 IgG-Associated Neurologic DisorderNEJM 386:173-180, Case 1-2022, 2022
Pembrolizumab-Induced Myasthenia GravisNeurol 91:e1365-e1367, Algaeed, M.,et al, 2018